ARTICLE | Clinical News
Edaravone regulatory update
June 27, 2016 7:00 AM UTC
Mitsubishi submitted an NDA to FDA for edaravone to treat amyotrophic lateral sclerosis. The IV cerebral neuroprotectant and free radical scavenger is marketed in Japan and South Korea as Radicut for ...